Clinical view of autosomal polycystic kidney disease;Obraz kliniczny autosomalnie dominuja̧cej wielotorbielowatości nerek

Polskie Archiwum Medycyny Wewnetrznej

Volumn 104, Issue 2, 2000, Pages 525-531

  Rózański, Jacek ^a   Myślak, Marek ^a   Domański, Leszek ^a   Ciechanowski, Kazimierz ^a   Szmatłoch, Eugeniusz ^a  

^a Klinika Chorob Wewnetrznych P   (Poland)

Author keywords

Autosomal dominant polycystic kidney disease; Hypertension; Renal failure

Indexed keywords

CARDIOVASCULAR DISEASE; CHEMISTRY; CHRONIC KIDNEY FAILURE; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY POLYCYSTIC DISEASE; NEPHROLITHIASIS; RENOVASCULAR HYPERTENSION; REVIEW;

CARDIOVASCULAR DISEASES; GASTROINTESTINAL DISEASES; HUMANS; HYPERTENSION, RENAL; KIDNEY CALCULI; KIDNEY FAILURE, CHRONIC; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT;

EID: 6144276595     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Griffin M., Gamble V., Milliner D. i wsp.: Neonatal presentation of autosomal dominant polycystic kidney disease with a maternal history of tuberous sclerosis. Nephrol. Dial. Transplant., 1997, 11, 228.
2. Milutinovitz J., Rust P.f. Fialkow P.J. i wsp.: Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease. Am. J. Kidney Dis., 1992, 19, 465.
3. Hateboer N., V Dijk M.A., Bogdanova N i wsp.: Comparison of phenotypes of plycystic kidney disease types 1 and 2. european PKD-1PKD2 Study Group. Lancet, 1999, 353, 103.
4. Gabow P.A., Johnson A.M., Kaehny W.D.: Factors affecting the progression of renal disease in autosomal dominant polycystic kidney disease. Kidney Int., 1992, 41, 1311.
5. Parfrey P.S., Barrett B.J.: Hypertension in autosomal dominant polycystic kidney disease. Curr. Opin. Nephrol. Hypertens., 1995, 4, 460.
6. Torres V.E., Donovan K.A., Scicli G. i wsp.: Synthesis of renin by tubulocystic epithelium in autosomal dominant polycystic kidney disease. Kidney Int., 1992, 42, 364.
7. Ecder T., Chapman A.B., Godela M. i wsp.: Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis., 2000, 35, 427.
8. Harden P.N., Geddes C., Rowe P.A. i wsp.: Polymorphisms in angiotensin-converting enzyme gene and progression of IgA nefropathy. Lancet, 1995, 345, 1540.
9. Fernandez-Llama P., Poch E., Oriola J. i wsp.: Angiotensin-converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int., 1998, 53, 1743.
10. Perez-Oller L., Torra R., Badenas C. i wsp.: Influence of the ACE gene polymorphism in the progression of renal failure in the autosomal polycystic kidney disease. Am. J. Kidney Dis., 1999, 34, 273.
11. van Dijk M.A., Breuning M.H., Peters D.J.M. i wsp.: The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant., 2000, 15, 836.
12. Pirson Y., Chauveau J.J., Grufeld J.P.: Autosomal dominant polycystic kidney disease. In Oxford Textbook of Clinical Nephrology. Oxford University Press. 1998, 2393.
13. Sklar A.H., Caruana R.J., Lammers J.E. i wsp.: Renal infections in autosomal polycystic kidney disease. Am. J. Kidney Dis., 1987, 10, 81.
14. Torres V.E., Wilson D.M., Hattery R.R. i wsp.: Renal stone disease in autosomal polycystic kidney disease. Am. J. Kidney Dis., 1993, 22, 513.
15. Torres V.E., Erickson S.B., Smith L.H. i wsp.: The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am. J. Kidney Dis., 1998, 11, 318.
16. Gabow P.A., Duley I., Johnson A.M.: Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis., 1992, 20, 140.
17. Beebe D.K.: Autosomal dominant polycystic kidney disease. Am. Fam. Physicians., 1996, 53, 925.
18. Simon P.: Prognosis of autosomal dominant polycystic kidney disease. Nephron, 1995, 71, 247.
19. Choukroun G., Itakura Y., Albouze G. i wsp.: Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol, 1995, 6, 1634.
20. Abbate M., Remuzzi G.: Proteinuria as a mediator of tubulointerstitial injury. Kidney Blood Press. Res., 1999, 22, 37.
21. Yeh J.: Albuminuria and cardiovascular disease risk factors in American Indians. Circulation, 1990, 82, 620.
22. Chauveau D., Pirson Y., Le Moine A. i wsp.: Extrarenal manifestations in autosomal dominant polycystic kidney disease. Adv. Nephrol., 1997, 26, 265.
23. Sherstha R., McKinely C., Russ P. i wsp.: Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology, 1997, 26, 1282.
24. Parks T.G.: Postmortem studies of the colon with special references to diverticular disease. Proc. R. Soc. Med., 1968, 61, 932.
25. Hannan C.E., Knightly J.J., Coffey R.J.: 423.
26. Sheff R.T., Zuckerman G., Harter H. i wsp.: Diverticular disease in patients with chronic renal failure due to polycystic kidney disease. Ann. Intern. Med., 1980, 92, 202.
27. Sharp C.K., Zeligman B.E., Johnson A.M. i wsp.: Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease. Am. J. Kidney Dis., 1999, 34, 863.
28. Danaci M., Akpolat T., Bastemir M. i wsp.: The prevalance of seminal vesicle cysts in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant., 1998, 13, 2825.
29. Gabow P.A.: Autosomal dominant polycystic kidney disease - more than a renal disease. Am. J. Kidney Dis., 1990, 16, 403.
30. Torra R., Nicolau C., Badenas C. i wsp.: Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol., 1997, 47, 19.
31. Hossack K.F. Leddy C.L., Johnson A.M. i wsp.: Echocardiographic findings in autosomal dominant polycystic kidney disease. N. Eng. J. Med., 1988, 319, 907.
32. Martinez-Vea A., Bardaji A., Gutierrez C. i wsp.: Echocardiographic evaluation in patients with autosomal dominant polycystic kidney disease and endstage renal disease. Am. J. Kidney Dis., 1999, 34, 264.
33. Chapman A.B., Rubinstein D., Hugkas R.: intracranial aneurysmas in autosomal dominant pocystic kidney disease. N. Engl. J. Med., 1992, 24, 916.
34. Huston J., Torres V.E., Sulivan P.P. i wsp.: Value of magnetic resonance agniography for the detection of intracranial aneurysms in autosomal dominant pocystic kidney disease. J. Am. Soc. Nephrol., 1993, 3, 1871.
35. Schievink W.I., Huston J., Torres V.A.: Intracranial ysts in autosomal dominant polycystic kidney disease. J. Neurosurg., 1995, 83, 1004.
36. Parsch C.S., Kraub J., Hofmann E. i wsp.: Arachnoid cysts associated with subdural hematomas and hygromas: analysis of 16 cases, longterm follow up, and review of the literature. Neurosurgery, 1997, 40, 483,
37. Schievink W.I., Torres V.E.: Spinal meningeal diverticula in autosomal dominant polycystic kidney disease. Lancet, 1997, 349, 1223.
38. Wijdicks E.F.M., Torres V.E., Schievink W.I.: Chronic subdural hematoma in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis., 2000, 35, 40.
39. Ravine D., Gibson R.N., Walker R.G. i wsp.: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet, 1994, 343, 824.
40. Ecder T., Edelstein C., Chapman A. i wsp.: Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant., 1999, 14, 113.
41. Pirson Y., Chauveau D.: Cystic disease of the kidney. In: Atlas of diseases of the kidney. Vol 2. editor R.W. Schrier, 1999 Current Medicine Inc.